Post-transcriptional control of c-erb B-2 overexpression in stomach cancer cells

被引:10
|
作者
Bae, CD
Juhnn, YS
Park, JB
机构
[1] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Kyungkido, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 110799, South Korea
来源
EXPERIMENTAL AND MOLECULAR MEDICINE | 2001年 / 33卷 / 01期
关键词
c-erb B-2; oncogene; overexpression; stomach cancer;
D O I
10.1038/emm.2001.3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The growth factor receptor oncogene, c-erb B-2, is frequently overexpressed in the adenocarcinomas of breast, ovary, lung and stomach. Although the mechanism of erb B-2 overexpression is thought as the result of transcriptional upregulation in many primary human carcinomas, expression rate of c-erb B-2 at mRNA level is usually lower than the level of translated protein. We also found that the expression of erb 8-2 in SNU-1 stomach cancer cells was greater at post-transcription level (Bae et al, 1993), To explore the underlying mechanism of erb 8-2 protein overexpression, we have chosen two cells lines, SNU-1 and SNU-16 where transcription rate of erb B-2 was closely resemble to each other while expressed protein levels were quite different. The synthesis rate of erb B-2 protein in SNU-1 cells was faster than SNU-16 cells while levels of erb B-2 mRNA were found to be similar in both cell lines. The half-life of the expressed erb B-2 protein was not significantly different in both cell lines. Analysis of the 5' untranslated region (UTR) of erb B-2 mRNA (-1 similar to -323) showed no sequence abnormality in both cell lines. However, ribonuclease protection assay using cloned 5 UTR sequence revealed that the size of 5' UTR of erb B-2 mRNA which associate with transcription initiation site(s) in SNU-1 cells was longer than that in SNU-16. These results suggest that the increased erb B-2 protein synthesis rate possibly due to the redundant selection of transcription initiation might be a mechanism of erb B-2 overexpression in SNU-1 cells.
引用
收藏
页码:15 / 19
页数:5
相关论文
共 50 条
  • [21] A SUBGROUP OF PATIENTS WITH CHRONIC-PANCREATITIS OVEREXPRESS THE C-ERB B-2 PROTOONCOGENE
    FRIESS, H
    YAMANAKA, Y
    BUCHLER, M
    HAMMER, K
    KOBRIN, MS
    BEGER, HG
    KORC, M
    ANNALS OF SURGERY, 1994, 220 (02) : 183 - 192
  • [22] EXPRESSION OF C-ERB B-2 ONCOGENE PRODUCT IN PERSISTENT GESTATIONAL TROPHOBLASTIC DISEASE
    CAMERON, B
    GOWN, AM
    TAMIMI, HK
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (06) : 1616 - 1622
  • [23] Protein overexpression and gene amplification of c-erb B-2 in pulmonary carcinomas:: A comparative immunohistochemical and fluorescence in situ hybridization study
    Hirashima, N
    Takahashi, W
    Yoshii, S
    Yamane, T
    Ooi, A
    MODERN PATHOLOGY, 2001, 14 (06) : 556 - 562
  • [24] IMMUNOHISTOCHEMICAL DETERMINATION OF C-ERB B-2 (NEU) ONCOGENE PRODUCT AS PROGNOSTIC PARAMETER IN BREAST-CANCER
    WITTLINGER, T
    COSTA, SD
    MIETZE, M
    HENDRIK, J
    KAUFMANN, M
    BASTERT, G
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1991, 250 (1-4) : 257 - 258
  • [25] The clinical utility of ER, PR, c-erb B-2 and UPA detection in effusions of breast cancer patients
    Makrantonakis, Parisis
    Valeri, Rosalia Maria
    Malle, Despoina
    Fotiou, Chariklea
    Dimitriadis, Konstantinos
    Destouni, Chariklea
    ANNALS OF ONCOLOGY, 2004, 15 : 31 - 31
  • [26] 幽门螺杆菌与胃癌C-erb B-2表达的关系
    杨作森
    房学东
    高勇
    中国老年学杂志, 2004, (02) : 112 - 113
  • [27] Prognostic significance of c-erb B-2 protein expression in carcinoma of the cervix treated with radiotherapy
    T. Nishioka
    C. M. L. West
    N. Gupta
    D. P. Wilks
    J. H. Hendry
    S. E. Davidson
    R. D. Hunter
    Journal of Cancer Research and Clinical Oncology, 1999, 125 : 96 - 100
  • [28] Dietary fatty acids regulate the activation status of Her-2/neu (c-erb B-2) oncogene in breast cancer cells
    Menendez, JA
    Ropero, S
    Lupu, R
    Colomer, R
    ANNALS OF ONCOLOGY, 2004, 15 (11) : 1719 - 1721
  • [29] THE SIGNIFICANCE OF C-ERB B-2 AND P53 IMMUNOREACTIVITY IN PATIENTS WITH ADENOCARCINOMA OF THE ESOPHAGUS
    DUHAYLONGSOD, FG
    GOTTFRIED, MR
    IGLEHART, JD
    VAUGHN, AL
    WOLFE, WG
    ANNALS OF SURGERY, 1995, 221 (06) : 677 - 684
  • [30] C-erb B-2 staining in primary synovial chondromatosis: A comparison with other cartilaginous tumours
    Davis, RI
    Foster, H
    Biggart, DJ
    JOURNAL OF PATHOLOGY, 1996, 179 (04): : 392 - 395